플루랄라너

동물 종별 용량

용량은 면허 수의 전문가를 위한 임상 참고 자료입니다. 항상 최신 라벨과 개별 환자에 대해 확인하십시오.

투여 경로

금기

• Known hypersensitivity to fluralaner or any excipients
• Use with caution in dogs or cats with pre-existing epilepsy or seizure disorders
• Known hypersensitivity to fluralaner
• Puppies less than 8 weeks of age or weighing less than 2 kg
• Kittens less than 11 weeks of age or weighing less than 1.2 kg

이상반응

• Vomiting
• Diarrhea
• Lethargy
• Decreased appetite
• Application site reactions (erythema, pruritus, alopecia for topical forms)
• Rare neurological signs (muscle tremors, ataxia, seizures)
• Neurologic signs (tremors, ataxia, seizures - rare)
• Application site reactions (erythema, pruritus - topical forms)

약물 상호작용

• Highly protein-bound drugs (e.g., NSAIDs, warfarin) · Fluralaner is highly bound to plasma proteins and might theoretically compete with other highly bound drugs, though clinical significance is generally low. · minor
• Highly protein-bound drugs (e.g., NSAIDs) · Fluralaner is highly protein-bound and may theoretically compete with other highly bound drugs, though clinical significance is generally considered low. · minor

모니터링

• Efficacy of parasite control
• Signs of gastrointestinal upset
• Neurological status (especially in animals with a history of seizures)
• Adverse neurologic signs (tremors, ataxia, seizures)

과용량

Fluralaner is generally well tolerated. In safety studies, oral administration of up to 5 times the maximum recommended dose in dogs produced no severe adverse effects. Overdoses may increase the risk of gastrointestinal upset or transient neurological signs. Treatment is symptomatic and supportive.